Final answer:
In Hemophilia A, expected laboratory values will reveal a deficiency in clotting factor VIII. This genetic disorder causes uncontrolled bleeding due to inadequate production of the factor necessary for blood clotting. Treatment usually involves the infusion of the missing clotting factors and may eventually be treated with genetic therapy.
Step-by-step explanation:
Hemophilia A is a genetic disorder characterized by the inability to synthesize sufficient quantities of factor VIII, which is critical for the blood clotting process. Expected laboratory values for a client with Hemophilia A would show a deficiency in this particular clotting factor. Unlike the buffy coat, which comprises the fraction of a blood sample containing most of the white blood cells and platelets following centrifugation, factor levels are directly quantified in the plasma. In individuals with hemophilia, deviations from normal clotting factor levels are indicative of the disorder, and they typically experience uncontrolled bleeding from minor injuries due to this deficiency. Treatment often involves regular infusions of clotting factors isolated from healthy donors to help prevent bleeding, and in the future, genetic therapy may provide a more definitive solution.